These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 8893142

  • 21. Disproportionally low clearance of macromolecules from the plasma to the peritoneal cavity in a mouse model of peritoneal dialysis.
    Rippe A, Rippe C, Swärd K, Rippe B.
    Nephrol Dial Transplant; 2007 Jan; 22(1):88-95. PubMed ID: 17050632
    [Abstract] [Full Text] [Related]

  • 22. High peritoneal residual volume decreases the efficiency of peritoneal dialysis.
    Wang T, Cheng HH, Heimbürger O, Bergström J, Lindholm B.
    Kidney Int; 1999 May; 55(5):2040-8. PubMed ID: 10231469
    [Abstract] [Full Text] [Related]

  • 23. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
    Scarpioni L, Ballocchi S, Castelli A, Scarpioni R.
    Perit Dial Int; 1994 May; 14(2):127-31. PubMed ID: 8043664
    [Abstract] [Full Text] [Related]

  • 24. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
    Wang T, Cheng HH, Heimbürger O, Waniewski J, Bergström J, Lindholm B.
    Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
    [Abstract] [Full Text] [Related]

  • 25. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.
    Wideröe TE, Smeby LC, Mjåland S, Dahl K, Berg KJ, Wessel Aas T.
    Nephron; 1984 Feb; 38(4):238-47. PubMed ID: 6514073
    [Abstract] [Full Text] [Related]

  • 26. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
    Triolo G, Carta Q, Salomone M, Dani F, Passarino G, Boggio Bertinet D, Segoloni GP, Vercellone A.
    Life Support Syst; 1983 Feb; 1 Suppl 1():454-6. PubMed ID: 6400733
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of intraperitoneal fluconazole during continuous cycling peritoneal dialysis.
    Dahl NV, Foote EF, Searson KM, Fein JL, Kapoian T, Steward CA, Sherman RA.
    Ann Pharmacother; 1998 Dec; 32(12):1284-9. PubMed ID: 9876807
    [Abstract] [Full Text] [Related]

  • 28. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
    Brouard RJ, Kapusnik JE, Gambertoglio JG, Schoenfeld PY, Sachdeva M, Freel K, Tozer TN.
    Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Ultrafiltration failure and dialysate glucose in CAPD.
    Stegmayr B, Granbom L, Karlsson UM, Lindqvist B.
    Adv Perit Dial; 1993 Jun; 9():62-4. PubMed ID: 8105964
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
    Rottembourg J, Balducci A, Baumelou A, Jacq D, Agrafiotis A, Slama G.
    Proc Clin Dial Transplant Forum; 1980 Jun; 10():305-7. PubMed ID: 7050993
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Nikolaidis P, Dombros N, Alexiou P, Balaskas E, Tourkantonis A.
    Perit Dial Int; 1989 Jun; 9(1):57-9. PubMed ID: 2488183
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H, Ragnaud JM, Demotes-Mainard F, Vincon G, Wone C.
    Eur J Clin Pharmacol; 1986 Jun; 30(3):299-302. PubMed ID: 3732364
    [Abstract] [Full Text] [Related]

  • 35. Insulin absorption from the peritoneal cavity.
    Zingg W, Leibel BS.
    Life Support Syst; 1985 Jun; 3(4):335-42. PubMed ID: 3906287
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V, Belicar P, Alessis C, Raccah D, Vialettes B, Vague P.
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [Abstract] [Full Text] [Related]

  • 39. Effect of intraperitoneal insulin on solute kinetics in CAPD: insulin kinetics in CAPD.
    Rubin J, Reed V, Adair C, Bower J, Klein E.
    Am J Med Sci; 1986 Feb; 291(2):81-7. PubMed ID: 3511700
    [Abstract] [Full Text] [Related]

  • 40. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC, Lai YH, Tsai CY, Shin SJ, Tsai JH.
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.